Medicare Enrolled

Dr. Brett Dolgin, D.O.

Procedural Dermatology Physician · Great Neck, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
255 GREAT NECK RD APT PH15, Great Neck, NY 11021
5163537086
In practice since 2012 (13 years)
NPI: 1417206459 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dolgin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dolgin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dolgin

Dr. Brett Dolgin is a procedural dermatology physician in Great Neck, NY, with 13 years of NPI registration. Based on federal Medicare data, Dr. Dolgin performed 5,239 Medicare services across 3,115 unique beneficiaries.

Between the years covered by Open Payments, Dr. Dolgin received a total of $17,165 from 39 pharmaceutical and/or device companies across 913 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in procedural dermatology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dolgin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ Top 16% volume in NY $17,165 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,239
Medicare services
Top 16% in NY for procedural dermatology physician
3,115
Unique beneficiaries
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~403 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
1,903 $6 $33
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
1,114 $76 $214
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
652 $49 $160
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
396 $91 $265
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
250 $95 $359
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
199 $105 $303
Shaving of skin growth, 0.6-1.0 cm
A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters.
189 $99 $308
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
153 $82 $512
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
80 $145 $395
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
64 $47 $359
Shaving of skin growth on face, 0.6-1.0 cm
This procedure involves shaving off a skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the growth being removed is between 0.6 and 1.0 centimeters.
43 $120 $359
Shaving of skin growth, 0.6-1.0 cm
A minor procedure to shave off a skin growth measuring 0.6 to 1.0 cm from the scalp, neck, hands, feet, or genitals.
40 $101 $308
Simple drainage of skin abscess
A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing.
23 $108 $299
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
21 $47 $184
Shaving of small skin growth on face or mouth area
A minor procedure to shave off a small skin growth, measuring 0.5 cm or less, located on the face, ears, eyelids, nose, lips, or mouth.
20 $96 $308
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
20 $1 $31
Shaving of skin growth, 1.1-2.0 cm
This procedure involves shaving off a skin growth measuring between 1.1 and 2.0 centimeters from the body, arms, or legs.
17 $118 $367
Destruction of cancer skin growth, 1.1-2.0 cm
Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters.
17 $146 $425
Intermediate wound repair, 2.6-7.5 cm
A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing.
15 $274 $723
Destruction of 15 or more precancerous skin growths
This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer.
12 $155 $401
Light therapy to destroy precancerous skin growth
This procedure uses light to treat and remove precancerous skin lesions. It is a method for destroying abnormal skin cells before they become cancerous.
11 $99 $331
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$17,165
Total received (2018-2024)
Avg $2,452/year across 7 years
Top 18% in NY for procedural dermatology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
913
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,065 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$100 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,529
2023
$3,272
2022
$2,808
2021
$1,777
2020
$1,006
2019
$2,155
2018
$1,618

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Arcutis Biotherapeutics, Inc.
$962
Janssen Biotech, Inc.
$663
Dermavant Sciences, Inc.
$537
Novartis Pharmaceuticals Corporation
$388
UCB, Inc.
$349
LEO Pharma Inc.
$306
SUN PHARMACEUTICAL INDUSTRIES INC.
$249
GENZYME CORPORATION
$205
PFIZER INC.
$146
ABBVIE INC.
$141
Lilly USA, LLC
$115
Ortho Dermatologics, a division of Bausch Health US, LLC
$96
Galderma Laboratories, L.P.
$85
Boehringer Ingelheim Pharmaceuticals, Inc.
$78
Incyte Corporation
$78
Verrica Pharmaceuticals Inc.
$52
Regeneron Healthcare Solutions, Inc.
$31
Amgen Inc.
$28
Paratek Pharmaceuticals, Inc.
$21
Top 3 companies account for 47.7% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$2,793
Novartis Pharmaceuticals Corporation
$2,173
Arcutis Biotherapeutics, Inc.
$1,026
LEO Pharma Inc.
$1,024
Dermavant Sciences, Inc.
$859
Galderma Laboratories, L.P.
$806
Sun Pharmaceutical Industries Inc.
$753
Lilly USA, LLC
$708
Ortho Dermatologics, a division of Bausch Health US, LLC
$647
AbbVie Inc.
$647
GENZYME CORPORATION
$638
Regeneron Healthcare Solutions, Inc.
$626
UCB, Inc.
$608
Incyte Corporation
$538
AbbVie, Inc.
$467
ABBVIE INC.
$391
SUN PHARMACEUTICAL INDUSTRIES INC.
$380
PFIZER INC.
$374
Amgen Inc.
$355
Celgene Corporation
$266
Boehringer Ingelheim Pharmaceuticals, Inc.
$206
Biofrontera Inc.
$118
SANOFI-AVENTIS U.S. LLC
$100
DERMIRA, INC.
$99
Medimetriks Pharmaceuticals, Inc.
$85
Genentech USA, Inc.
$61
Paratek Pharmaceuticals, Inc.
$60
Verrica Pharmaceuticals Inc.
$52
DUSA Pharmaceuticals, Inc.
$45
MAYNE PHARMA COMMERCIAL LLC
$43
Kyowa Kirin, Inc.
$40
E.R. Squibb & Sons, L.L.C.
$39
Mayne Pharma Inc.
$34
Helsinn Therapeutics (U.S.), Inc.
$33
Taro Pharmaceuticals USA, Inc.
$17
Almirall LLC
$16
Journey Medical Corporation
$13
Merck Sharp & Dohme Corporation
$13
STRATA Skin Sciences, Inc.
$11
Top 3 companies account for 34.9% of all-time payments
Associated products mentioned in payments ›
0.25% · 20% · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMELUZ · ANGLED BLADE PLATES · ARAZLO · Absorica LD · Ameluz · BLU-U · BRYHALI · Bimzelx · CIBINQO · COSENTYX · CYLTEZO · Cabtreo · Cimzia · Clodan · DERMATITIS - DISEASE · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Erivedge · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Klisyri · LEVULAN KERASTICK · LIBTAYO · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · NUZYRA · OLUMIANT · ONEXTON · OPZELURA · ORACEA · Otezla · POTELIGEO · QBREXZA · REMICADE · RETIN-A-MICRO · RINVOQ · SILIQ · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · Skyrizi · Sotyktu · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · TWYNEO · Tremfya · VALCHLOR · VTAMA · Winlevi · XTRAC · YCANTH · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a procedural dermatology physician in Great Neck?
Compare procedural dermatology physicians in the Great Neck area by procedure volume, costs, and industry payment transparency.
Browse procedural dermatology physicians nearby

Geographic Context

Procedural dermatology physicians within 10 mi
71
Per 100K population
5.1
County median income
$143,408
Nearest hospital
NORTH SHORE UNIVERSITY HOSPITAL
2.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Dolgin is a clinical cardiology specialist, with above-average Medicare volume (top 16% in NY), with low-engagement industry engagement in the top 18% of NY peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Dolgin experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Dolgin performed 1,903 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dolgin receive payments from pharmaceutical companies?
Yes. Dr. Dolgin received a total of $17,165 from 39 companies across 913 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dolgin's costs compare to other procedural dermatology physicians in Great Neck?
Dr. Dolgin's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dolgin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →